Molecular Analysis and Treatment Options of SCLC
Status
Conditions
Treatments
Details and patient eligibility
About
Small cell lung cancer (SCLC) is an aggressive disease that is characterized by rapid growth and the early development of metastases. Patients typically respond to initial chemotherapy but quickly experience relapse, resulting in a poor long-term outcome. Therapeutic innovations that substantially improve survival have historically been limited, and reliable, predictive biomarkers are lacking.
Ongoing research has advanced the understanding of molecular categories and the immunologic microenvironment of SCLC, which in turn has helped improve disease classification and staging. Considering the role of molecular alterations has not yet fully to be defined in the treatment of SCLC, there is an urgent recognition that molecular alterations in the SCLC are important to predict response and survival for novel therapies and ongoing clinical trials. Advances in research have revealed critical information regarding biologic characteristics of the disease, which may lead to the identification of vulnerabilities and the development of new therapies. Further research focused on identifying biomarkers and evaluating innovative therapies will be paramount to improving treatment outcomes for patients with SCLC.
In summary, identification of (genetic) biomarkers in SCLC is increasingly essential to perform molecular diagnostics and individualized treatments. This project aims to create a registry of patients with SCCL to further the characterization of molecular alterations and develop (novel) treatments based on the detection.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Histologically proven diagnosis of SCLC
- 18 years of age or older
- Ability to understand and the willingness to sign a written informed consent document
Exclusion criteria
- Histologically proven diagnosis of non-SCLC
Trial contacts and locations
Loading...
Central trial contact
Xiaomin Niu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal